perfluorohexyloctane
Sign in to saveAlso known as 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane | perfluorohexyloctane | Novaliq F6H8semifluorinated alkane (SFA) F6H8
Perfluorohexyloctane (branded as Evotears, Miebo, and Novatears, among others) is a medication used for the treatment of dry eye disease. It is a semifluorinated alkane.
Key facts
- Drug.image
- Perfluorohexyloctane.svg
- Drug.image_class
- skin-invert-image
- Drug.tradename
- EvotearsMiebo ( )Novatears
- Drug.MedlinePlus
- a623054
- Drug.DailyMedID
- Perfluorohexyloctane
- Drug.routes_of_administration
- Eye drops
- Drug.ATC_prefix
- None
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.CAS_number
- 133331-77-8
- Drug.PubChem
- 10477896
- Drug.DrugBank
- DB17823
- Drug.ChemSpiderID
- 8653305
- Drug.UNII
- 7VYX4ELWQM
- Drug.KEGG
- D12604
- Drug.ChEBI
- 229658
- Drug.synonyms
- NOV03; 1-(perfluorohexyl)octane
- Drug.IUPAC_name
- 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane
via Wikipedia infobox
~1 min read
Encyclopedic overview
6 sectionsContents
- Medical uses
- Availability
- Side effects
- See also
- Notes and references
- Further reading
Perfluorohexyloctane (branded as Evotears, Miebo, and Novatears, among others) is a medication used for the treatment of dry eye disease. It is a semifluorinated alkane.
Perfluorohexyloctane has been available in multiple markets since 2015 under the brand names Evotears and Novatears, and was additionally approved for medical use in the United States in May 2023 under the brand name Miebo. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.
Excerpted from Wikipedia’s “perfluorohexyloctane” article, available under the CC BY-SA 4.0 licence.